Press Releases

4/25/2012
NeoGenomics Reports 72% Revenue Growth, 85% Gross Profit Growth and $1.5 Million Increase in Net Income for Q1 2012
Ft. Myers, Florida – April 25, 2012 - NeoGenomics, Inc. (NASD OTC QB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2012.

4/17/2012
NeoGenomics Schedules its Q1 2012 Earnings Release for April 25, 2012
Ft. Myers, Florida – April 17, 2012 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its first quarter 2012 financial results on Wednesday April 25, 2012.

3/28/2012
NeoGenomics Announces Increase in the Maximum Availability Under its Revolving Credit Facility
Ft. Myers, Florida – March 28, 2012 – NeoGenomics, Inc. (NASD OTC QB: NGNM) announced today that it had reached an agreement with CapitalSource Finance LLC to amend its revolving credit facility. The amendment increased the maximum availability of the facility from $5.0 million to $8.0 million based on eligible accounts receivable and gives the Company the right to request up to two additional $1.0 million increases in such availability in the future. The amendment also provides for a 1.0% per annum decrease in the overall interest rate based on current LIBOR rates and extends the term of the facility through March 26, 2015.

3/5/2012
NeoGenomics Announces Upward Revision to Q1 2012 Revenue Guidance
Ft. Myers, Florida – March 5, 2012 – NeoGenomics, Inc. (NASD OTCQB: NGNM) announced today that it was revising upward its previously issued revenue guidance for the first quarter of 2012. The Company now expects revenue of approximately $14.5 - $15.0 million for the first quarter, an increase from the prior guidance of $13.5 - $14.0 million released on February 16, 2012. At the $14.75 million midpoint of this revised guidance range, first quarter revenue would be 68% higher than it was in the first quarter of last year.

2/16/2012
NeoGenomics Reports 47% Revenue Growth and Profitability for Q4 2011; Provides Financial Outlook for 2012
Ft. Myers, Florida – February 16, 2012 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter and full year 2011.

2/7/2012
NeoGenomics Schedules its Q4 and Full Year 2011 Earnings Release for February 16, 2012
Ft. Myers, Florida – February 7, 2012 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its fourth quarter and full year 2011 financial results on Thursday February 16, 2012.

1/9/2012
NeoGenomics Enters Into Exclusive Worldwide Licensing Agreement With Health Discovery Corporation
Ft. Myers, Florida – January 9, 2012 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, announced today that it has licensed from Health Discovery Corporation (“HDC”, OTCBB: HDVY) the exclusive worldwide rights to utilize HDC’s extensive intellectual property portfolio to develop laboratory developed tests (“LDTs”) and other products relating to hematopoietic and solid tumor cancers.

1/9/2012
NeoGenomics Appoints Dr. Maher Albitar as Chief Medical Officer
Ft. Myers, Florida – January 9, 2012 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, announced today the appointment of Dr. Maher Albitar as Chief Medical Officer and Director of Research and Development.

1/4/2012
NeoGenomics Appoints Dr. Barbara Chaitin as Director of Surgical Pathology and Medical Director for its Florida Lab
Ft. Myers, Florida – January 4, 2012 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, announced today the appointment of Dr. Barbara Chaitin as Director of Surgical Pathology for NeoGenomics Laboratories and Medical Director of the Fort Myers, Florida laboratory.

12/6/2011
NeoGenomics Announces Upward Revisions to its Q4 2011 Revenue Guidance
Ft. Myers, Florida – December 6, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it was revising upward its previously issued revenue guidance for Quarter 4, 2011.

12/5/2011
NeoGenomics to Present at the 4th Annual LD MICRO Growth Conference
Ft. Myers, Florida – December 5, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it will present at the 4th Annual LD MICRO Growth Conference on Thursday, December 8, 2011 at 9:30 AM.

10/19/2011
NeoGenomics Reports Third Quarter 2011 Results
Ft. Myers, Florida – Oct. 19, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter 2011.

10/5/2011
NeoGenomics Schedules its Q3 2011 Earnings Release for October 19, 2011
Ft. Myers, Florida – Oct. 5, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its third quarter 2011 financial results before the market opens on Wednesday, October 19, 2011.

9/1/2011
NeoGenomics to Present at the Rodman & Renshaw Healthcare Investment Conference on September 12, 2011
Ft. Myers, Florida – September 1, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it will present at the Rodman & Renshaw Annual Healthcare Investment Conference being held from September 11-13, 2011 at the Waldorf Astoria Hotel in New York City.

7/20/2011
NeoGenomics Reports Second Quarter 2011 Results
Ft. Myers, Florida - July 20, 2011 - NeoGenomics, Inc (NASD OTC BB: NGNM), a leadering provider of cancer-focused genetic testing services today reported its results for the second quarter 2011.

7/12/2011
NeoGenomics Schedules its Q2 2011 Earnings Release for July 20, 2011
Ft. Myers, Florida – July 12, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its second quarter 2011 financial results on Wednesday, July 20, 201

4/21/2011
NeoGenomics Reports First Quarter 2011 Results
Ft. Myers, Florida – April 21, 2011 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2011.

4/15/2011
NeoGenomics Schedules its Q1 2011 Earnings Release for April 21, 2011
Ft. Myers, Florida – April 15, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its first quarter 2011 financial results on Thursday, April 21, 2011.

2/10/2011
NeoGenomics Reports Fourth Quarter and Full Year 2010 Results
Ft. Myers, Florida – February 10, 2011 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010.

2/10/2011
NeoGenomics Announces Changes to its Board of Directors
Ft. Myers, Florida – February 10, 2011 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services announced today that Kevin C. Johnson and Raymond R. Hipp have joined its Board of Directors. Mr. Johnson’s appointment was effective October 28, 2010 and filled the vacancy created by the resignation of Mr. George O’Leary. Mr. Hipp’s appointment was effective as of February 3, 2011 and filled the vacancy created by the resignation of Dr. Marvin Jaffe.

1/12/2011
NeoGenomics Announces Equity Raise from Insiders and Existing Shareholders at $1.50/Share
Ft. Myers, Florida – January 12, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it has completed a $3.0 million equity financing transaction. Five members of the Company’s Board of Directors and senior management team and two existing institutional investors of the Company participated in the transaction.

1/11/2011
Qui Tam Complaint Against NeoGenomics Dismissed
Ft. Myers, Florida – January 11, 2011 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it has been notified that the Qui Tam complaint filed against it and several other healthcare companies in 2009 has been voluntarily dismissed with prejudice by the relator in the case. As a result, no further action will be taken against NeoGenomics in this matter.

10/28/2010
NeoGenomics Reports Third Quarter 2010 Results
Ft. Myers, Florida – October 28, 2010 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter 2010.

8/10/2010
NeoGenomics Announces Executive Appointments
Ft. Myers, Florida – August 10, 2010 - NeoGenomics, Inc. (NASD OTC BB: NGNM), announced today that Grant Carlson has been appointed Vice President of Business Development and that Mark W. Smits will join the company as Vice President of Sales & Marketing on August 30, 2010.

7/29/2010
NeoGenomics Reports Second Quarter 2010 Results
Ft. Myers, Florida – July 29, 2010 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the second quarter 2010.

7/7/2010
NeoGenomics Provides Early Look at Second Quarter Results
Ft. Myers, Florida – July 7, 2010 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it expects to report second quarter revenue of approximately $8.5 million and a net loss of approximately ($0.02) – ($0.03) per share. Revenues and test volumes increased by approximately 14% and 28%, respectively, compared to last year’s second quarter.

6/2/2010
NeoGenomics to Present at Noble Financial’s 6th Annual
Ft. Myers, Florida – June 2, 2010 - NeoGenomics, Inc. (NASD OTC BB: NGNM) today announced that it will present at the Sixth Annual Noble Financial Equity Conference at 12:30 PM EST on Monday, June 7, 2010 at the Seminole Hard Rock Hotel in Hollywood, FL.

4/29/2010
NeoGenomics Reports First Quarter Results
Ft. Myers, Florida – April 29, 2010 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2010.

2/25/2010
NeoGenomics Reports Fourth Quarter and Full Year 2009 Results
Ft. Myers, Florida – February 25, 2010 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter 2009 and fiscal year ended December 31, 2009.

2/19/2010
NeoGenomics Schedules its Q4 and Full Year 2009 Earnings Release for February 25, 2010
Ft. Myers, Florida – February 19, 2010 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its fourth quarter and full year 2009 financial results on Thursday, February 25, 2010.

1/31/2010
NeoGenomics Announces Anticipated Restructuring Charges for Q4 2009
Ft. Myers, Fla., Jan. 7 -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it intends to take up to $500,000 in certain restructuring and other charges in the fiscal quarter ending December 31, 2009. These charges will cover costs in connection with restructuring the company's management team, including various severance obligations and recent recruiting fees. In addition, the Company is in the process of restructuring its relationship with Response Genetics, which provides NeoGenomics with KRAS-based molecular testing, which was unprofitable for the Company in 2009

12/15/2009
NeoGenomics Announces the Appointment of Jack G. Spitz as Vice President of Laboratory Operations
Ft. Myers, Florida – December 15, 2009 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that Jack G. Spitz has been appointed Vice President of Laboratory Operations. Mr. Spitz will be responsible for managing all laboratory operational affairs of the Company.

12/4/2009
NeoGenomics Announces Executive Appointments
Ft. Myers, Florida – December 4, 2009 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that Steven C. Jones has been appointed Executive Vice President, Finance and that George A. Cardoza has joined the company as Chief Financial Officer. Mr. Cardoza will be responsible for managing all internal financial affairs of the Company. In his new role, Mr. Jones will focus on developing strategic initiatives on behalf of NeoGenomics as well as continue to serve as the Company’s Director of Investor Relations.

11/12/2009
NeoGenomics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
Ft. Myers, Florida – November 12, 2009 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference being held November 17-18, 2009, at the St. Regis, New York Hotel in New York City. The conference will showcase public and private life sciences and biotech companies. Senior executives of attending companies will make presentations to portfolio managers and analysts on their business strategy and outlook. One-on-one meetings with interested parties will also be arranged during the three-day conference.

10/29/2009
NeoGenomics Reports Third Quarter 2009 Results
Ft. Myers, Florida – October 29, 2009 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2009.

7/28/2009
NeoGenomics Reports Second Quarter 2009 Results
Ft. Myers, Florida – July 28, 2009 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the second quarter of 2009.

6/5/2009
NeoGenomics to Present at Noble Financial’s 5th Annual Equity Conference on Monday, June 8th
Ft. Myers, Florida – June 5, 2009 - NeoGenomics, Inc. (NASD OTC BB: NGNM) today announced that it will present at the Fifth Annual Noble Financial Equity Conference at 9:15 AM EST on Mnday, June 8, 2009 at the Seminole Hard Rock Hotel in Hollywood, FL.

4/23/2009
NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
Ft. Myers, Florida – April 23, 2009 - NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, today reported its results for the first quarter ended March 31, 2009.

3/16/2009
NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
Ft. Myers, Florida – March 16, 2009 – NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer genetics testing services, announced today that Douglas M. VanOort, 53 years old, has joined the Company’s Board of Directors and been appointed Executive Chairman and Interim Chief Executive Officer.

3/5/2009
NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
Ft. Myers, Florida – March 5, 2009 - NeoGenomics, Inc. (NASD OTC BB: NGNM), an operator of a network of cancer-focused testing laboratories, today announced its results for the fourth quarter and full–year ended December 31, 2008.

2/19/2009
NeoGenomics Schedules its Q4 and Full Year 2009 Earnings Release for February 25, 2010
Ft. Myers, Florida – February 19, 2010 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its fourth quarter and full year 2009 financial results on Thursday, February 25, 2010.

11/7/2008
NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10
Ft. Myers, Florida – November 7, 2008 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that President and Chief Scientific Officer, Bob Gasparini, will present at the Rodman & Renshaw 10th Annual Healthcare Conference being held from November 10-12, 2008 at the New York Palace Hotel in New York City.

11/6/2008
NeoGenomics Announces Results for the Third Quarter of Fiscal Year 2008
Ft. Myers, Florida – November 6, 2008 - NeoGenomics, Inc. (NASD OTC BB: NGNM) today announced its results for the third quarter of FY 2008.

9/29/2008
NeoGenomics Laboratories Extends Its Cancer Testing Services Through Exclusive Agreement with Response Genetics, Inc.
Fort Myers, Florida, September 29, 2008 – NeoGenomics Laboratories (OTCBB: NGNM), a national clinical reference laboratory specializing in high-complexity, cancer-specific testing, announced today an exclusive agreement with Response Genetics Inc.

8/12/2008
NeoGenomics to Present at the Noble Financial Equity Conference
Ft. Myers, Florida – August 12, 2008 - NeoGenomics, Inc. (NASD OTC BB: NGNM) today announced that it will present at the Fourth Annual Noble Financial Equity Conference at 1:30 p.m.(Pacific) on Monday, August 18, 2008 at the Loews Lake Las Vegas Resort, Nevada.

7/31/2008
NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
Ft. Myers, Florida – July 31, 2008 - NeoGenomics, Inc. (NASD OTC BB: NGNM) today announced its results for the second quarter of 2008.

5/7/2008
NeoGenomics Announces Results for the First Quarter of Fiscal Year 2008
Ft. Myers, Florida – May 7, 2008 - NeoGenomics, Inc. (NASD OTC BB: NGNM) today announced its results for the first quarter of fiscal 2008.

5/5/2008
NeoGenomics Schedules its Q1 2008 Earnings Release for May 7, 2008
Ft. Myers, Florida – May 5, 2008 – NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it plans to release its first quarter 2008 financial results on Wednesday, May 7, 2008.

3/18/2008
NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
Ft. Myers, Florida – March 18, 2008 - NeoGenomics, Inc. (NASD OTC BB: NGNM) today announced its results for the fourth quarter and full year of fiscal 2007.

3/15/2008
NeoGenomics Files Annual Report on Form 10-KSB with the SEC
Ft. Myers, Florida – April 15, 2008 - NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that it had filed with the Securities and Exchange Commission its annual report on Form 10-KSB for the year ended December 31, 2007.